Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 EUR | 0.00% | -9.14% | -28.39% |
04-11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
03-26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.39% | 501M | |
+20.26% | 42.68B | |
-2.28% | 42.4B | |
+45.21% | 40.04B | |
-6.20% | 28.31B | |
+6.45% | 24.94B | |
-21.62% | 18.96B | |
+30.49% | 12.3B | |
-2.87% | 11.95B | |
-3.64% | 11.55B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva Starts Rolling Submission Of US FDA Biologics License Application For Chikungunya Vaccine